![Rouven Bingel-Erlenmeyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rouven Bingel-Erlenmeyer is the founder of CDR-Life AG, serving as Chief Technology Officer since 2017.
Former job includes Head-Downstream Processing & Analytics at ESBATech, a Novartis Co. GmbH.
| Sociétés | Poste | Début |
|---|---|---|
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology Operates as a biotherapeutics company | Fondateur | 01/01/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Corporate Officer/Principal | 01/05/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
CDR-Life Inc.
CDR-Life Inc. BiotechnologyHealth Technology Operates as a biotherapeutics company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
